Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingqiang Lei

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Translational Medicine|May 7, 2026
IGFBP in tumor immunity: a novel target for cancer immunotherapyQingqiang Lei, Liangbin Lin, Hui Yu
Frontiers in Oncology|September 8, 2023
Case Report: A rare case of recurrent ascites after anti-Claudin18.2 antibody therapy for metastatic gastric cancer while responding sustaininglyJinlu Liu, Dan Jiang, Qingqiang Lei, et al.
Scientific Reports|May 24, 2024
Identification and clinical validation of diverse cell-death patterns-associated prognostic features among low-grade gliomasWenyong Yang, Hui Yu, Qingqiang Lei, et al.
American Journal of Cancer Research|July 15, 2024
Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcomeLiangbin Lin, Hui Yu, Xuelu Xie, et al.
Molecular Biomedicine|October 30, 2024
Systemic lupus erythematosus: pathogenesis and targeted therapyXu Su, Hui Yu, Qingqiang Lei, et al.
Autoimmunity Reviews|May 20, 2026
B cells in systemic lupus erythematosus: From pathogenic mechanisms to targeted therapiesXu Su, Qingqiang Lei, Xuerui Chen, et al.
Frontiers in Immunology|April 2, 2024
Mechanism study of ubiquitination in T cell development and autoimmune diseaseHui Yu, Wenyong Yang, Min Cao, et al.
Science Signaling|October 10, 2023
TRIM55 promotes noncanonical NF-κB signaling and B cell-mediated immune responses by coordinating p100 ubiquitination and processingLiangbin Lin, Hui Yu, Li Li, et al.
Frontiers in Cell and Developmental Biology|March 16, 2026
FAM-related prognostic molecular subtype screening identified epithelial-derived <i>MAOA</i>-inhibiting bladder cancerHui Yu, Qingqiang Lei, Wenyong Yang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Translational Medicine|May 7, 2026
IGFBP in tumor immunity: a novel target for cancer immunotherapyQingqiang Lei, Liangbin Lin, Hui Yu
Frontiers in Oncology|September 8, 2023
Case Report: A rare case of recurrent ascites after anti-Claudin18.2 antibody therapy for metastatic gastric cancer while responding sustaininglyJinlu Liu, Dan Jiang, Qingqiang Lei, et al.
Scientific Reports|May 24, 2024
Identification and clinical validation of diverse cell-death patterns-associated prognostic features among low-grade gliomasWenyong Yang, Hui Yu, Qingqiang Lei, et al.
American Journal of Cancer Research|July 15, 2024
Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcomeLiangbin Lin, Hui Yu, Xuelu Xie, et al.
Molecular Biomedicine|October 30, 2024
Systemic lupus erythematosus: pathogenesis and targeted therapyXu Su, Hui Yu, Qingqiang Lei, et al.
Autoimmunity Reviews|May 20, 2026
B cells in systemic lupus erythematosus: From pathogenic mechanisms to targeted therapiesXu Su, Qingqiang Lei, Xuerui Chen, et al.
Frontiers in Immunology|April 2, 2024
Mechanism study of ubiquitination in T cell development and autoimmune diseaseHui Yu, Wenyong Yang, Min Cao, et al.
Science Signaling|October 10, 2023
TRIM55 promotes noncanonical NF-κB signaling and B cell-mediated immune responses by coordinating p100 ubiquitination and processingLiangbin Lin, Hui Yu, Li Li, et al.
Frontiers in Cell and Developmental Biology|March 16, 2026
FAM-related prognostic molecular subtype screening identified epithelial-derived <i>MAOA</i>-inhibiting bladder cancerHui Yu, Qingqiang Lei, Wenyong Yang, et al.
Pageof 1